GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Cyclically Adjusted FCF per Share

Read-Gene (WAR:RDG) Cyclically Adjusted FCF per Share : zł-0.06 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Read-Gene's adjusted free cash flow per share for the three months ended in Mar. 2024 was zł-0.004. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is zł-0.06 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-06), Read-Gene's current stock price is zł4.74. Read-Gene's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was zł-0.06. Read-Gene's Cyclically Adjusted Price-to-FCF of today is .


Read-Gene Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Read-Gene's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Cyclically Adjusted FCF per Share Chart

Read-Gene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.05 -0.05 -0.06

Read-Gene Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.06 -0.06 -0.06

Competitive Comparison of Read-Gene's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Read-Gene's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Read-Gene's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Read-Gene's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Read-Gene's Cyclically Adjusted Price-to-FCF falls into.



Read-Gene Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Read-Gene's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.004/149.0435*149.0435
=-0.004

Current CPI (Mar. 2024) = 149.0435.

Read-Gene Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.090 101.180 -0.133
201409 -0.002 100.611 -0.003
201412 0.090 100.122 0.134
201503 -0.064 100.041 -0.095
201506 -0.116 100.448 -0.172
201509 0.036 99.634 0.054
201512 0.015 99.471 0.022
201603 -0.037 98.983 -0.056
201606 0.063 99.552 0.094
201609 0.025 99.064 0.038
201612 -0.047 100.366 -0.070
201703 0.242 101.018 0.357
201706 -0.291 101.180 -0.429
201709 -0.059 101.343 -0.087
201712 0.060 102.564 0.087
201803 0.177 102.564 0.257
201806 0.025 103.378 0.036
201809 -0.036 103.378 -0.052
201812 -0.172 103.785 -0.247
201903 0.007 104.274 0.010
201906 -0.113 105.983 -0.159
201909 0.005 105.983 0.007
201912 -0.116 107.123 -0.161
202003 0.005 109.076 0.007
202006 -0.046 109.402 -0.063
202009 -0.010 109.320 -0.014
202012 0.078 109.565 0.106
202103 -0.021 112.658 -0.028
202106 -0.008 113.960 -0.010
202109 -0.032 115.588 -0.041
202112 0.070 119.088 0.088
202203 0.012 125.031 0.014
202206 -0.071 131.705 -0.080
202209 0.064 135.531 0.070
202212 0.025 139.113 0.027
202303 0.009 145.950 0.009
202306 -0.045 147.009 -0.046
202309 -0.043 146.113 -0.044
202312 0.018 147.741 0.018
202403 -0.004 149.044 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Read-Gene  (WAR:RDG) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Read-Gene Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Read-Gene's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Read-Gene (WAR:RDG) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003
Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene (WAR:RDG) Headlines

No Headlines